1. Unmet need for interprofessional education in paediatric cancer: a scoping review

   • Martha Krogh Topperzer
   • Marianne Hoffmann
   • Jette Led Sørensen

   Review Article Open access 24 May 2019 Pages: 3627 - 3637

   

2. Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies

   • Silvia Triarico
   • Michele Antonio Capozza
   • Antonio Ruggiero

   Review Article 01 June 2019 Pages: 3639 - 3645

3. Psychological aspects, risk and protective factors related to BRCA genetic testing: a review of the literature

   • Lucia Lombardi
   • Sonia M. Bramanti
   • Alessandra Cavallo

   Review Article 15 June 2019 Pages: 3647 - 3656

   

4. A systematic review of body image measures for people diagnosed with head and neck cancer (HNC)

   • Chindhu Shunmuga Sundaram
   • Haryana M. Dhillon
   • Claudia Rutherford

   Review Article 15 June 2019 Pages: 3657 - 3666

   

5. The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy

   • Judith A. E. M. Zecha
   • Judith E. Raber-Durlacher
   • Ludi E. Smeele

   Review Article Open access 20 June 2019 Pages: 3667 - 3679

6. Deglutition disorders as a consequence of head and neck cancer therapies: a systematic review and meta-analysis

   • Isabela Porto de Toledo
   • Leticia Lopes Quirino Pantoja
   • Eliete Neves Silva Guerra

   Review Article 22 June 2019 Pages: 3681 - 3700

   

7. The effects of Tai Chi on quality of life of cancer survivors: a systematic review and meta-analysis

   • Xiaosha Ni
   • Raymond Javan Chan
   • Yan Lou

   Review Article 24 June 2019 Pages: 3701 - 3716

   

8. Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: a systematic review and meta-analysis

   • Nadia Miladi
   • Richi Dossa
   • Bruno Gagnon

   Review Article 28 June 2019 Pages: 3717 - 3727

   

9. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview

   • Alexandre Chan
   • Daniel L. Hertz
   • Maryam B. Lustberg

   Review Article 30 July 2019 Pages: 3729 - 3737

   

10. Health concerns of cancer survivors after primary anti-cancer treatment

    • S. Y. Tan
    • J. Turner
    • Janette L. Vardy

    Original Article 01 February 2019 Pages: 3739 - 3747

    

11. Cost-utility analysis of aprepitant for patients who truly need it in Japan

    • Ikuto Tsukiyama
    • Masahiko Ando
    • Akihito Kubo

    Original Article 01 February 2019 Pages: 3749 - 3758

    

12. Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial

    • Xin Hua
    • Lin-Min Chen
    • Ling Guo

    Original Article Open access 02 February 2019 Pages: 3759 - 3767

    

13. A feasibility study examining the impact of yoga on psychosocial health and symptoms in pediatric outpatients receiving chemotherapy

    • Eliana Stein
    • Meera Rayar
    • Lillian Sung

    Original Article 02 February 2019 Pages: 3769 - 3776

    

14. Screening for clinical insomnia in cancer patients with the Edmonton Symptom Assessment System-Revised: a specific sleep item is needed

    • Josée Savard
    • Hans Ivers

    Original Article 04 February 2019 Pages: 3777 - 3783

    

15. A cross-sectional population-based survey looking at the impact of cancer survivorship care plans on meeting the needs of cancer survivors in the posttreatment stage

    • Soleil Chahine
    • Robin Urquhart

    Original Article 05 February 2019 Pages: 3785 - 3792

16. Objective assessment of WHO/ECOG performance status

    • Miha Sok
    • Miha Zavrl
    • Matevž Srpčič

    Original Article 05 February 2019 Pages: 3793 - 3798

    

17. Adherence and quality of life in women with breast cancer being treated with oral hormone therapy

    • Rebeca Stahlschmidt
    • Amanda Canato Ferracini
    • Priscila Gava Mazzola

    Original Article 06 February 2019 Pages: 3799 - 3804

18. Combined decongestive therapy and reduction of pain and heaviness in patients with breast cancer-related lymphedema

    • Zahra Sheikhi Mobarakeh
    • Parisa Mokhtari-Hesari
    • Fatemeh Zekri

    Original Article 07 February 2019 Pages: 3805 - 3811

    

19. Characteristics of adverse events of endocrine therapies among older patients with breast cancer

    • Naoko Honma
    • Masujiro Makita
    • Shinji Ohno

    Original Article 07 February 2019 Pages: 3813 - 3822

    

20. Personalised and progressive neuromuscular electrical stimulation (NMES) in patients with cancer—a clinical case series

    • Dominic O’Connor
    • Matilde Mora Fernandez
    • Brian Caulfield

    Original Article 08 February 2019 Pages: 3823 - 3831

    

21. Duration of anticoagulant therapy and VTE recurrence in patients with cancer

    • Alok A. Khorana
    • Keith R. McCrae
    • Jeff Schein

    Original Article Open access 08 February 2019 Pages: 3833 - 3840

    

22. Getting control during follow-up visits: the views and experiences of parents on tumor surveillance after their children have completed therapy for rhabdomyosarcoma or Ewing sarcoma

    • B. Vaarwerk
    • P. F. Limperg
    • M. A. Grootenhuis

    Original Article Open access 12 February 2019 Pages: 3841 - 3848

23. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy

    • J. Matt McCrary
    • David Goldstein
    • Susanna B. Park

    Original Article 12 February 2019 Pages: 3849 - 3857

    

24. Optimizing antiresorptive treatment in patients with bone metastases: time to initiation, switching strategies, and treatment duration

    • AnneMarthe Mjelstad
    • Gustav Zakariasson
    • Antonis Valachis

    Original Article Open access 13 February 2019 Pages: 3859 - 3867

    

25. Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

    • Jesus Vera
    • Jonas Paludo
    • Svetomir N. Markovic

    Original Article 14 February 2019 Pages: 3869 - 3875

    

26. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory

    • Jiil Chung
    • Girish S. Kulkarni
    • Jennifer M. Jones

    Original Article Open access 14 February 2019 Pages: 3877 - 3885

    

27. Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial

    • Margrethe Langer Bro
    • Christoffer Johansen
    • Jeppe Gram

    Original Article 14 February 2019 Pages: 3887 - 3896

    

28. Pruritus in patients with solid tumors: an overlooked supportive care need

    • Jaxon J. Vallely
    • Kathryn E. Hudson
    • Thomas W. LeBlanc

    Original Article 14 February 2019 Pages: 3897 - 3904

    

29. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors

    • Melisa L. Wong
    • Bruce A. Cooper
    • Christine Miaskowski

    Original Article 15 February 2019 Pages: 3905 - 3912

    

30. Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy

    • Stephen Rajan Samuel
    • Arun G. Maiya
    • Karen M. Mustian

    Original Article 27 March 2019 Pages: 3913 - 3920

    

31. Correction to: Priorities of a “good death” according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey

    • Young Ho Yun
    • Kyoung-Nam Kim
    • Kyung Hae Jung

    Correction 16 July 2019 Pages: 3921 - 3926

32. Special Section on the MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis - 2019 Update

    News 08 July 2019 Pages: 3927 - 3927

33. The MASCC/ISOO Mucositis Guidelines 2019 Update: introduction to the first set of articles

    • Sharon Elad

    Editorial 08 July 2019 Pages: 3929 - 3931

34. Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods

    • Vinisha Ranna
    • Karis Kin Fong Cheng
    • On behalf of the Mucositis Study group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO)

    Special Article 08 July 2019 Pages: 3933 - 3948

35. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines

    • Catherine H. L. Hong
    • Luiz Alcino Gueiros
    • On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO)

    Special Article 08 July 2019 Pages: 3949 - 3967

    

36. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines

    • Yehuda Zadik
    • Praveen R. Arany
    • On behalf of The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)

    Special Article 08 July 2019 Pages: 3969 - 3983

    

37. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines

    • Anura Ariyawardana
    • Karis Kin Fong Cheng
    • On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO)

    Special Article 08 July 2019 Pages: 3985 - 3995

    

38. Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines—part 1: vitamins, minerals, and nutritional supplements

    • Noam Yarom
    • Allan Hovan
    • On behalf of The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO)

    Special Article 08 July 2019 Pages: 3997 - 4010

39. Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines

    • Joanne M. Bowen
    • Rachel J. Gibson
    • On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)

    Special Article 08 July 2019 Pages: 4011 - 4022

    

40. The pathogenesis of mucositis: updated perspectives and emerging targets

    • J. Bowen
    • N. Al-Dasooqi
    • On behalf of The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)

    Special Article 08 July 2019 Pages: 4023 - 4033